Research and systematic reviews have primarily focused on v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) genes as potential prognostic biomarkers for CRC. This evidence concerns the gene BRAF and colorectal carcinoma.